Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04060238
Other study ID # ProLight_I
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 7, 2020
Est. completion date March 15, 2020

Study information

Verified date June 2019
Source Aalen University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The aim of the offered project is to investigate the influence of protanopia (red blindness) or protanomaly (red vision weakness) on the recognizability of red brake lights with the help of a test person study. From this, estimates of the influence of protanopia or protanomaly on driving ability are to be derived.

If a relevant influence can be demonstrated in the study, recommendations for action for the legislator will be made.

Translated with www.DeepL.com/Translator


Description:

Protanopia is an x-chromosomal inherited cone pigment disorder that related to the red cone,i.e. the L-cone function completely fails. The prevalence of protanopia in the male population is 1%. An incomplete impairment of the L-cone is called protanomaly. The prevalence here is also in 1% of the male population.

In comparison to persons with normal vision red objects appear darker for persons with missing or functionally limited L-cones. This is particularly critical in road traffic, where red is used as a signal colour, for example in traffic lights or brake lights is used.

The scientific questions that need to be investigated are as follows:

1. At which contrast threshold (relative brightness) does a proband with protanopia recognize a brake light compared to a normal person?

2. If the luminance determined is above the contrast threshold, what influence does the excess of the contrast or the determined luminance have on the reaction time?

3. Are there differences with regard to the technology used in the brake light (incandescent lamp or LED)?

For this purpose, a representative set of combination rear lamps, focusing on stoplight, taillight (and of the elevated brake light) in a static situation is created. The test setup is based on a driving pursuit scenario. The test person is positioned at a relevant distance to the combination of rear lamps.

To determine the threshold contrast, an algorithm is developed to control the relative brightness of the brake lights and integrated into the test sequence control. In addition, a method for automated determining of the related reaction time is implemented.

Two taillight technologies (incandescent lamp and LED) are examined at both ambient brightness levels: (i) "bright", i.e. photopic luminance level (Lu >> 10 cd/m2) and (ii) "dark", i.e. mesopic luminance level (Lu < 10 cd/m2).

A comprehensive ophthalmological/optical examination (including visual acuity, ocular alignment, ocular motility, assessment of the leading eye, testing of the efferent and afferent pupillary system and biomicroscopic inspection of the anterior and posterior segments of the eye) is carried out. Comprehensive colour vision testing it performed with the HMC anomaloscope, Oculus Inc., Dutenhofen/FRG, including assessment of the loss of brightness sensation during anomaloscopic exam with max. red. stimulus . In addition, standardized semi-automated kinetic perimetry (SKP) along the horizontal meridian with an automated perimeter (Octopus 900, Haag-Streit Inc., Koeniz/CH) is performed. The ratio of the horizontal extent ("diameter") obtained with both, red vs. white stimuli, is measured and taken as a clinical parameter for quantifying the magnitude of the individual "protan colour vision deficiency".

To illustrate the worst-case scenario, this study is limited to protanopic patients. It is intended as a pure comparative study between a "protanopic" patient group and a "normal vision" control group. The protanopic test subjects and the control subjects are matched with regard to gender and age.

This study is carried out in a "within-subject design", i.e. all test persons go through all situations. In order to minimize sequence effects, the related test conditions are randomized.


Recruitment information / eligibility

Status Completed
Enrollment 16
Est. completion date March 15, 2020
Est. primary completion date March 15, 2020
Accepts healthy volunteers
Gender Male
Age group 18 Years and older
Eligibility Inclusion Criteria:

- informed consent

- male

- age (greater or equal) 18 years

Exclusion Criteria:

- binocular (high contrast) distant visual acuity worse than 0.8 (16/20)

- spherical ametropia exceeding 8 dpt

- cylindrical ametropia exceeding 2.5 dpt

- manifest strabismus (squint) with diplopia

- relative afferent pupillary defect exceeding 0.3 log units

- anamnestic (patient history) OR morphological (slit lamp --> anterior segment, ophthalmoscope --> retina) clue/indicator for a ophthalmologically relevant affection of the eye OR the visual pathway

- S.p. severe ocular trauma

- Current OR s.p. severe intraocular inflammation

- S.p. intraocular surgery within the past three months

Study Design


Intervention

Diagnostic Test:
Anomaloscope (colour vision test)
The Heidelberg Multi Colour (HMC) Anolmaloscope (Oculus Inc., Dutenhofen/FRG) is used to differentiate between normal controls (normal trichromatopsia) and test subjects with protanopia ("inherited red colour blindness")

Locations

Country Name City State
Germany Ulrich SCHIEFER Aalen Deutschland

Sponsors (2)

Lead Sponsor Collaborator
Aalen University Karlsruhe Institute of Technology (KIT), Karlsruhe/FRG

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Contrast sensitivity (I) Contrast sensitivity between taillight and brake light under two luminance conditions within one year
Secondary Reaction time Time span within the onset of the brake light and the reaction of the tested subject within one year
Secondary Contrast sensitivity (II) taillight technology: incandescent lamp vs. light emitting diode (LED) within one year
Secondary Reaction time (II) taillight technology: incandescent lamp vs. light emitting diode (LED) within one year
Secondary Perimetric extent of horizontal meridian (Semi-autmated kinetic) perimetry with white vs. red stimuli within one year
Secondary Loss of brightness sensation during anomaloscopic exam Loss of brightness sensation during anomaloscopic exam with max. red. stimulus within one year
See also
  Status Clinical Trial Phase
Completed NCT05926050 - The Acute Effects of a Dietary Supplement on Cognitive Performance in Highly Trained Athletes. N/A
Completed NCT05998096 - A Randomized Study to Examine the Ability of a Caffeine-Based Energy Drink to Impact Energy Expenditure, Fat Oxidation, Reaction Time, and Other Perceptual Indicators N/A
Completed NCT03439930 - The Effect of Balance Training on Neuromuscular Control in Subjects With CAI N/A
Completed NCT01972581 - Neurocognitive Visual Reaction Training N/A
Completed NCT05839743 - Investigation of the Effects of Aerobic Exercise, Balance Exercise and Combined Exercise Practices on Frailty, Balance, Fall Risk, Reaction Time, Cognitive Functions and Quality of Life in Dementia Patients N/A
Completed NCT01592175 - Magnetoencephalography (MEG), Attention and Conscience
Completed NCT03903250 - Effects of A-GPC on Reaction Time and Cognitive Function N/A
Completed NCT04859153 - Relevant Factors on Sprint Performance in Adolescent Sprinters
Completed NCT02203539 - The Influence of Light Exposure on Exercise Performance Dependent on Chronotype. N/A
Not yet recruiting NCT06461221 - tFUS to Enhance Alertness and Performance Phase 1
Completed NCT06168747 - Reaction Time After Mobilization N/A
Recruiting NCT06308731 - Exercise-Induced Rates of Fat Oxidation With and Without Ingestion of a Caffeine-Based Energy Drink N/A
Not yet recruiting NCT05472727 - Comparison of Physical Fitness, Walking Speed, Reaction Time In Older Adults With and Without Mild Cognitive Impairment